Оценка влияния традиционных факторов кардиоваскулярного риска и воспаления на структурные характеристики артериальной стенки при псориатическом артрите
https://doi.org/10.14412/1995-4484-2009-1146
Аннотация
Об авторах
Т. В. КоротаеваE Y Loginova
E S Mach
Д. С. Новикова
E N Alexandrova
Евгений Львович Насонов
N N Firsov
Список литературы
1. <div><p>Кардиология. Нац. Руководство. Под ред. Ю.Н. Беленкова, Р.Г. Оганова М, ГЭОТАР, Медиа, 2007, 1232 .</p><p>Artiss J. D., Zak B. Measurement of cholesterol concentration. In: Rifai N., Warmic G. R., Dominiczak M. H., eds. Handbook of lipoprotein testing. Washington: AACC Press, 1997, 99-114.</p><p>Barker S. G., Talbert A., Cottam S. et al. Arterial intimal hyperplasia after occlusion of the adventitial vasa vasorum in the pig. Arterioscler. Thromb., 1993, 13, 70-7.</p><p>Barker S. G., Tilling L. C., Miller G. C. et al. The adventitia and atherogenesis: removal initiates intimal proliferation in the rabbit which regresses on generation of a “neoadventitia”. Atherosclerosis, 1994, 105, 131-44.</p><p>Doyle B., Caplice N. Plaque neovascularization and antiangiogenic therapy for atherosclerosis. J. Am. Coll. Cardiol., 2007, 49, 2073-80.</p><p>Friedwald W. T., Levy R. J., Fredrickson D. S. Estimation of the calculation of LDL cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem., 1972, 18, 499-502</p><p>Gladman D., Helliwell P., Mease P. et al. Assesment of patients with Psoriatic Arthritis. Arthritis Rheum., 2004, 50(1), 24-35.</p><p>Gladman D., Rahman P. Psoriatic arthritis, 6th edn, Chap 71. WB Saunders, Philadelphia, 2001, 253 p.</p><p>Gladman D. D., Farewell V. T., Wong K. et al. Mortality studies in psoriatic arthritis: results from a single outpatient center. 2. Prognostic indicators for death. Arthritis Rheum., 1998, 41, 1103-10.</p><p>Gonzalez-Juanatey C., Llorca J., Amigo-Diaz E. et al. High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum., 2007, 57(6), 1074-80.</p><p>Han C., Robinson D. W. Jr, Hackett M. V. et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. J. Rheumatol., 2006, 33, 2167-72</p><p>Hahn B. H, Grossman J., Chen W. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia. J. Autoim., 2007, 28 (2-3), 69-75.</p><p>Haverkate F., Thompson S. G., Pyke S. D. M. et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet, 1997, 349, 462-66.</p><p>Herrmann J., Lerman L, O., Mukhopadhyay D. et al. Angiogenesis in Atherogenesis. Arterioscl. Thromb. Vasc. Biology, 2006, 26, 1948-57.</p><p>Kimhi O., Caspi D., Bornstein N. M. et al. Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Sem. Arthritis Rheum., 2007, 36 (4), 203-9.</p><p>Leong T.T., Fearon U., Veale D.J. Angiogenesis in psoriasis and psoriatic arthritis: Clues to disease pathogenesis. Curr. Rheum. Rep., 2005, 7(4), 325-9.</p><p>Mash F., Lovis C., Gaspoz J. M. et al. C-reactive protein as a marker for acute coronary syndrome. Eur. Heart. J., 1997, 18, 1897-902.</p><p>Moll J. M. H., Wright V. Psoriatic arthritis. Semin. Arthritis Rheum., 1973, 3, 55-78.</p><p>Peters M. J., v d Horst-Bruinsma I. E., Dijkmans B. et at. Cardiovascular risk profile of patients with spon- dylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin. Arthritis Rheum., 2004, 34, 585-92.</p><p>Pignoli P., Longo T. Ultrasound evaluation of atherosclerosis. Methodological problems and technological developments Eur. Surg. Res., 1986, 18, 238-53</p><p>Rotstein R., Landau T., Twig A. et al. The erythrocyte adhesiveness/aggregation test (EAAT). A new biomarker to reveal the presence of low grade subclinical smoldering inflammation in individuals with athero- sclerotic risk factors. Atherosclerosis, 2002, 165(2), 343-51.</p><p>Grundy S. M., Pasternak R., Greenland Ph. et al. Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations. Circulation, 1999, 100, 1481-92</p><p>Taylor W., Gladman D., Helliwell P. et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum., 2006, 54, 2665–73.</p><p>Versari D., Gossl M., Mannheim D. et al. Hypertension and hypercholesterolemia differentially affect the function and structure of pig carotid artery. Hypertension, 2007, 50, 1063-68.</p><p>Williams J. K., Armstrong M. L., Heistad D. D. Vasa vasorum in atherosclerotic coronary arteries responses to vasoactive stimuli and regression of atherosclerosis. Circ. Res., 1988, 62, 515-23.</p><p>Wong K., Gladman D., Husted J. et al. Mortality studies in psoriatic arthritis: results from a single outpatient clinic. 1. Causes and risk of death. Arthritis Rheum., 1997, 40, 1868-72.</p><p>Young B., Gleeson M., Cripps A. C-reactive protein: a critical review. Pathology, 1991, 23, 118-24.</p></div><br />
Рецензия
Для цитирования:
Коротаева Т.В., Loginova E.Y., Mach E.S., Новикова Д.С., Alexandrova E.N., Насонов Е.Л., Firsov N.N. Оценка влияния традиционных факторов кардиоваскулярного риска и воспаления на структурные характеристики артериальной стенки при псориатическом артрите. Научно-практическая ревматология. 2009;47(4):20-25. https://doi.org/10.14412/1995-4484-2009-1146
For citation:
Korotaeva T.V., Loginova E.Y., Mach E.S., Novikova D.S., Alexandrova E.N., Nasonov E.L., Firsov N.N. Assessment of influence of traditional cardiovascular risk factors and inflammation on arterial wall structural characteristics in psoriatic arthritis. Rheumatology Science and Practice. 2009;47(4):20-25. (In Russ.) https://doi.org/10.14412/1995-4484-2009-1146